Welcome to our book review site go-pdf.online!

You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.

Sign up

Index of Patents Issued from the United States Patent and Trademark Office
  • Language: en
  • Pages: 1968

Index of Patents Issued from the United States Patent and Trademark Office

  • Type: Book
  • -
  • Published: 1992
  • -
  • Publisher: Unknown

None

Cancer Immunotherapy & Immuno-monitoring: Mechanism, Treatment, Diagnosis, and Emerging Tools
  • Language: en
  • Pages: 98

Cancer Immunotherapy & Immuno-monitoring: Mechanism, Treatment, Diagnosis, and Emerging Tools

In the past decade, significant progresses have taken place in the field of cancer immunotherapy. Tumor-targeting immunotherapies are being developed for most human cancers, including melanoma, prostate cancer, glioblastoma, sarcoma, lung carcinoma and hepatocellular carcinoma. The FDA has approved multiple molecular immunotherapeutics, such as Ipilimumab; cellular immunotherapies (e.g. adoptive cell transfer) are being tested in phase II/III clinical trials. Immunotherapetics has evolved into a sophisticated field: Multimodal therapeutic regimens are administrated to induce focused responses, curtail side- effects and improve therapeutic efficacy. The lack of effective clinical assessment t...

Index of Patents Issued from the United States Patent Office
  • Language: en
  • Pages: 2270

Index of Patents Issued from the United States Patent Office

  • Type: Book
  • -
  • Published: 1973
  • -
  • Publisher: Unknown

None

Progress Report
  • Language: en
  • Pages: 372

Progress Report

  • Type: Book
  • -
  • Published: 1992
  • -
  • Publisher: Unknown

None

Innate Immune Regulation and Cancer Immunotherapy
  • Language: en
  • Pages: 476

Innate Immune Regulation and Cancer Immunotherapy

Innate and adaptive immunity play important roles in immunosurveillance and tumor destruction. However, increasing evidence suggests that tumor-infiltrating immune cells may have a dual function: inhibiting or promoting tumor growth and progression. Although regulatory T (Treg) cells induce immune tolerance by suppressing host immune responses against self- or non self-antigens, thus playing critical roles in preventing autoimmune diseases, they might inhibit antitumor immunity and promote tumor growth. Recent studies demonstrate that elevated proportions of Treg cells are present in various types of cancers and suppress antitumor immunity. Furthermore, tumor-specific Treg cells can inhibit immune responses only when they are exposed to antigens presented by tumor cells. Therefore, Treg cells at tumor sites have detrimental effects on immunotherapy directed to cancer.

Inflammation and Immunity in Cancer
  • Language: en
  • Pages: 270

Inflammation and Immunity in Cancer

  • Type: Book
  • -
  • Published: 2015-03-26
  • -
  • Publisher: Springer

This book overviews cancer immunity from broad scientific fields, based on the concept that cancer is a sort of by-product of infection, inflammation, and host immune response. The innate and acquired arms of the immune system mainly participate in tumor immune surveillance, and their activation is critically modulated by the situation of the tumor microenvironment. Many types of immune cells join the formation of the microenvironment. In particular, macrophages and dendritic cells enter the tumor mass to be main players in the inflammatory milieu of tumors. After introducing these topics, the book discusses immunotherapy for cancer patients as an outgrowth of this concept of infection and inflammation. With the contributions of leading scientists actively involved in the field of antitumor immunity study, this book encourages readers to understand the mechanism of general cancers based on inflammation and will facilitate prevention and the development of therapeutics for cancer.

Official Gazette of the United States Patent and Trademark Office
  • Language: en
  • Pages: 1376

Official Gazette of the United States Patent and Trademark Office

  • Type: Book
  • -
  • Published: 2001
  • -
  • Publisher: Unknown

None

Resistance of Cancer Cells to CTL-Mediated Immunotherapy
  • Language: en
  • Pages: 364

Resistance of Cancer Cells to CTL-Mediated Immunotherapy

  • Type: Book
  • -
  • Published: 2015-06-20
  • -
  • Publisher: Springer

This comprehensive volume explores the latest research on the mechanisms of resistance in cancer cells to CTL-mediated immunotherapy. Chapter topics discuss cell-mediated immunity as the result of cytotoxic T-lymphocytes (CTL) directed specifically against cancer cells. In addition, the volume reviews how CTL mediate the cytotoxic activity, in large part, by the indication of apoptosis; hence, tumor cells develop anti-apoptotic mechanisms and thereby, resist CTL-induced apoptosis. In order for CTL-mediated antitumor immunotherapy to be effective, it is essential that agents directed against the resistant tumor cells sensitized cancer cells for CTL-mediated apoptosis. Examples of such agents discussed in the volume include are HDAC inhibitors, proteasome inhibitors, Bcl-2 family inhibitors, PARP, antibodies, and more.

Published Scientific Papers of the National Institutes of Health
  • Language: en
  • Pages: 564

Published Scientific Papers of the National Institutes of Health

  • Type: Book
  • -
  • Published: 1990
  • -
  • Publisher: Unknown

Presents the broad outline of NIH organizational structure, theprofessional staff, and their scientific and technical publications covering work done at NIH.

Advances in Cancer Research
  • Language: en
  • Pages: 241

Advances in Cancer Research

Volume 70 begins with two "Foundations in Cancer Research" articles, a staple of the Advances in Cancer Research series. The first article by Michael Stoker presents a review of some of the early advances made by cancer cell biology researchers. The second article by Emmanuel Farber describes the methods by which researchers delineate the phenotype of cells and ways to alter these phenotypes to prevent or delay carcinomas. Chidambaram and Dean illustrate the tumors and associated malformations of nevoid basal cell carcinoma. Koli and Keski-Oja review the effects of how transforming growth factor-b regulates cell proliferation, differentiation, and morphogenesis and its regulation by the ster...